Speeding Study Start-Up in Multicenter Clinical Trials

Speeding Study Start-Up in Multicenter Clinical Trials

This white paper is part of DIA’s White Paper Library

Managing an efficient, well-organized start-up phase is critical to overall study success. While IRB review is just one element of the study start-up process, the IRB can play a crucial role in reaching key study milestones in multisite clinical trials for sponsors, CROs, and research sites. By partnering early and communicating openly with your IRB, researchers and study sponsors can see a significant reduction in time spent on the initial IRB review process, which can influence and improve overall study start-up timelines and success.

Download Now!

First Name:

Last Name:

Job Title:

Organization:

Email Address:

By clicking "Submit", I share my information with the White Paper provider. I understand that the White Paper provider may contact me with messages asking me to consider use of their products and services:

INTERESTED IN PUBLISHING?

For more information on publishing your White Paper with DIA, including schedule and pricing, please contact Heej Ko at [email protected].